Public risk perception of non-prescription medicines and information disclosure during consultations: a suitable target for intervention?

There is general low public risk perception of NPMs. Individuals with higher risk perception are less likely to disclose information. Interventions that raise risk perception are unlikely to enhance the safe and effective supply of NPMs.